Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -12,50k | 1,53M | Automatic Disposition | 118,81 - 124,74 | 175,00k | -6,67% |
| 2026-07-06 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -26,25k | 3,13M | Derivative Exercise and Sale | 2,80 - 124,61 | 175,00k | - |
| 2026-07-01 | Ms. Nancy JohnsonSVP of Sales & Commercial Operations | -801,00 | 100,06k | Automatic Disposition | 124,91 | 21,10k | -3,66% |
| 2026-06-29 | Dr. John ten BoschSVP of Laboratory Operations | -1,42k | 169,92k | Automatic Disposition | 120,00 | 33,55k | -4,05% |
| 2026-06-24 | Ms. Shan Riku SakakibaraChief Product Officer | -4,00k | 440,00k | Automatic Disposition | 110,00 | 208,00k | -1,89% |
| 2026-06-24 | Ms. Shan Riku SakakibaraChief Product Officer | -4,00k | 405,40k | Derivative Exercise and Sale | 8,65 - 110,00 | 208,00k | - |
| 2026-06-15 | Dr. John ten BoschSVP of Laboratory Operations | -2,83k | 287,36k | Automatic Disposition | 101,47 | 34,97k | -7,49% |
| 2026-06-15 | Dr. David TsaoCo-Founder, President, CTO & Director | -20,00k | 1,99M | Derivative Exercise and Sale | 2,80 - 104,47 | 1 000,00 | - |
| 2026-06-09 | NeoTribe VenturesSociété | -435,95k | 0,00 | Other Disposition | - | 3,49M | -11,11% |
| 2026-06-08 | Ms. Shan Riku SakakibaraChief Product Officer | -8,00k | 785,80k | Automatic Disposition | 96,45 - 100,00 | 212,00k | -3,64% |
| 2026-06-08 | Ms. Nancy JohnsonSVP of Sales & Commercial Operations | -14,00k | 1,40M | Automatic Disposition | 99,09 - 102,34 | 21,90k | -39,00% |
| 2026-06-08 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -36,25k | 2,49M | Derivative Exercise and Sale | 2,80 - 100,87 | 187,50k | - |
| 2026-06-08 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -12,50k | 1,23M | Automatic Disposition | 96,45 - 100,00 | 187,50k | -6,25% |
| 2026-06-08 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -10,00k | 0,00 | Other Disposition | - | 2,22M | -0,45% |
| 2026-05-11 | NeoTribe VenturesSociété | -441,37k | 0,00 | Other Disposition | - | 3,92M | -10,11% |
| 2025-11-07 | Hummingbird Ventures Management NVSociété | -7,71M | 0,00 | Derivative Exercise and Sale | - | - | - |
| 2025-11-07 | Hummingbird Ventures Management NVSociété | -180,00k | 0,00 | Other Disposition | - | - | - |
| 2025-11-07 | Mr. Thomas P. LynchCCO, General Counsel & Secretary | -600,00 | 0,00 | Other Disposition | - | - | - |
| 2025-11-07 | Mr. Thomas P. LynchCCO, General Counsel & Secretary | -144,40k | 0,00 | Other Derivative Disposition | 8,65 - 30,78 | 0,00 | -100,00% |
| 2025-11-07 | Mr. Thomas P. LynchCCO, General Counsel & Secretary | 100,00 | 6,00k | Achat | 60,00 | 700,00 | 16,67% |
| 2025-11-07 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -262,43k | 0,00 | Derivative Exercise and Sale | - | - | - |
| 2025-11-07 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -2,17M | 0,00 | Other Disposition | - | - | - |
| 2025-11-07 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -1,64M | 0,00 | Other Derivative Disposition | 2,80 - 20,04 | 0,00 | -100,00% |
| 2025-11-07 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -2,23M | 0,00 | Other Disposition | - | 200,00k | -91,76% |
| 2025-11-07 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -2,23M | 0,00 | Other Disposition | - | 2,23M | -50,00% |
| 2025-11-07 | Dr. David TsaoCo-Founder, President, CTO & Director | -2,33M | 0,00 | Other Disposition | - | - | - |
| 2025-11-07 | Dr. David TsaoCo-Founder, President, CTO & Director | -1,14M | 0,00 | Other Derivative Disposition | 2,80 - 20,04 | 0,00 | -100,00% |
| 2025-11-07 | Dr. David TsaoCo-Founder, President, CTO & Director | 1 000,00 | 60,00k | Achat | 60,00 | 1 000,00 | - |
| 2025-11-07 | Dr. David TsaoCo-Founder, President, CTO & Director | -2,33M | 0,00 | Other Disposition | - | 1 000,00 | -99,96% |
| 2025-11-07 | Ms. Shan Riku SakakibaraChief Product Officer | -220,00k | 0,00 | Other Disposition | - | 220,00k | -50,00% |
| 2025-11-07 | Ms. Shan Riku SakakibaraChief Product Officer | -155,00k | 0,00 | Other Derivative Disposition | 2,80 - 30,78 | 0,00 | -100,00% |
| 2025-11-07 | Dr. John ten BoschSVP of Laboratory Operations | 800,00 | 48,00k | Achat | 60,00 | 37,80k | 2,16% |
| 2025-11-07 | Dr. John ten BoschSVP of Laboratory Operations | -37,00k | 0,00 | Other Disposition | - | 37,80k | -49,47% |
| 2025-11-07 | Dr. John ten BoschSVP of Laboratory Operations | -131,00k | 0,00 | Other Derivative Disposition | 0,56 - 30,78 | 0,00 | -100,00% |
| 2025-11-07 | Mr. Ross TaylorCFO | -250,00k | 0,00 | Other Derivative Disposition | 11,55 - 30,78 | 0,00 | -100,00% |
| 2025-11-07 | Mr. John D. ListerChief Administrative Officer | -133,30k | 0,00 | Other Derivative Disposition | 23,15 | 0,00 | -100,00% |
| 2025-11-07 | Ms. Nancy JohnsonSVP of Sales & Commercial Operations | 6,90k | 414,00k | Achat | 60,00 | 35,90k | 23,79% |
| 2025-11-07 | Ms. Nancy JohnsonSVP of Sales & Commercial Operations | -29,00k | 0,00 | Other Disposition | - | 35,90k | -44,68% |
| 2025-11-07 | Ms. Nancy JohnsonSVP of Sales & Commercial Operations | -275,00k | 0,00 | Other Derivative Disposition | 0,45 - 30,78 | 0,00 | -100,00% |
| 2025-11-07 | Mr. Akshay RaiIndependent Director | 2,50k | 150,00k | Achat | 60,00 | 5,18k | 93,42% |
| 2025-11-07 | Wipro Enterprises Private LimitedSociété | -1,78M | 0,00 | Derivative Exercise and Sale | - | - | - |
| 2025-11-07 | Mr. Akshay RaiIndependent Director | 2,68k | 0,00 | Derivative Exercise and Retained Stock | - | - | - |
| 2025-11-07 | Mr. Akshay RaiIndependent Director | -11,01k | 0,00 | Other Disposition | - | - | - |
| 2025-11-07 | Mr. Krishna Swaroop KolluriIndependent Director | -8,33k | 0,00 | Other Disposition | - | - | - |
| 2025-11-07 | Adams Street Partners, LLCSociété | 41,67k | 2,50M | Achat | 60,00 | 1,71M | 2,50% |
| 2025-11-07 | Adams Street Partners, LLCSociété | -1,67M | 0,00 | Derivative Exercise and Sale | - | 1,71M | - |
| 2025-11-07 | Mr. Thomas S. BremnerIndependent Director | -8,33k | 0,00 | Other Disposition | - | 0,00 | -100,00% |
| 2025-11-07 | FundRock Management Company S.A.Société | -277,51k | 0,00 | Derivative Exercise and Sale | - | 277,51k | - |
| 2025-11-07 | Hummingbird Ventures Management NVSociété | 7,71M | 0,00 | Derivative Exercise and Retained Stock | - | 7,89M | 4 281,79% |
| 2025-11-07 | Hummingbird Ventures Management NVSociété | -7,89M | 0,00 | Other Disposition | - | 7,89M | -50,00% |
| 2025-11-07 | Mr. Firat IleriLead Independent Director | 28,98k | 0,00 | Derivative Exercise and Retained Stock | - | 28,98k | - |
| 2025-11-07 | Mr. Firat IleriLead Independent Director | -37,31k | 0,00 | Other Disposition | - | 28,98k | -56,28% |
| 2025-11-07 | NeoTribe VenturesSociété | -4,24M | 0,00 | Derivative Exercise and Sale | - | - | - |
| 2025-11-07 | NeoTribe VenturesSociété | -120,00k | 0,00 | Other Disposition | - | - | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.